HBV-related cirrhosis progression correlated with IL-17A and IL-22 production by ILC3s, suggesting ILC3 promotion of fibrosis, likely in part due to IL-22-mediated suppression of anti-fibrotic IFN-γ (Figure 7A) (259). The gene discussed is IL22; the disease is Cirrhosis.